Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 10, 2017
[ Tue, Oct 10th 2017
] - WOPRAI
[ Tue, Oct 10th 2017
] - WOPRAI
[ Tue, Oct 10th 2017
] - WOPRAI
[ Tue, Oct 10th 2017
] - WOPRAI
[ Tue, Oct 10th 2017
] - WOPRAI
[ Tue, Oct 10th 2017
] - WOPRAI
[ Tue, Oct 10th 2017
] - WOPRAI
Mon, October 9, 2017
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
[ Mon, Oct 09th 2017
] - WOPRAI
Michael Yee Maintained (URGN) at Strong Buy with Increased Target to $37 on, Oct 9th, 2017
Michael Yee of Jefferies, Maintained "UroGen Pharma Ltd." (URGN) at Strong Buy with Increased Target from $27 to $37 on, Oct 9th, 2017.
Michael, nor any peers, have made any analyst calls on URGN in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Similar Stocks and Investing Articles
[ Fri, Oct 06th 2017
] - WOPRAI
[ Fri, Oct 06th 2017
] - WOPRAI
[ Wed, Oct 04th 2017
] - WOPRAI
[ Fri, Aug 18th 2017
] - WOPRAI
[ Fri, Oct 23rd 2015
] - WOPRAI
[ Wed, Oct 07th 2015
] - WOPRAI
[ Mon, Oct 15th 2012
] - WOPRAI
[ Fri, Mar 09th 2012
] - WOPRAI
[ Thu, Feb 09th 2012
] - WOPRAI